This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Health Insurers, Amid Historic Vote, Mired in Risk

WASHINGTON ( TheStreet) -- On the eve of reform, health insurers that were in a fit of palpitations over possible profit erosion released their lobbyists, America's Health Insurance Plans (AHIP), to snuff out pending legislation.

Health-insurance companies thought this day would never come. Decade after decade, the industry raised prices faster than inflation and resisted reform while laughing all the way to the bank. Given a seat at the table, they figured that if they played along with a popular president, they could shape the bill to their liking or quietly undermine it with screaming town-hall protesters.

The health-insurance companies miscalculated. AHIP issued a report threatening to raise insurance premiums even further if senators and representatives pass the $829 billion plan, which would require Americans to obtain insurance yet impose restrictions on insurance companies from denying coverage on pre-existing conditions.

Insanely high health-care costs have finally pushed legislative gridlock past the breaking point.

Finance Committee Chairman Max Baucus called for a vote on his health-care reform plan on Tuesday that would get the bill out of committee and off to the floor for melding with the health-reform bills of other committees. The Baucus plan passed by a party-line vote of 14 to 9, with all Democratic Party senators voting in support and all but one Republican in opposition. In a crossover "yes" vote, Sen. Olympia Snowe of Maine warned fellow Republicans and conservative Democrats not to be caught on the wrong side of history on the issue. Her support makes finding a filibuster-proof block of 60 votes easier to secure for final passage.
1 of 3

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free
KIE $63.93 -0.68%
IAK $46.25 -0.49%
AET $99.22 -2.83%
AIZ $78.48 -0.20%
AFL $58.21 0.33%


Chart of I:DJI
DOW 16,204.97 -211.61 -1.29%
S&P 500 1,880.05 -35.40 -1.85%
NASDAQ 4,363.1440 -146.4150 -3.25%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs